Albireo Pharma inc (ALBO) Annual Balance Sheets

Annual · GAAP · USD millions
Access ALBO quarterly Balance Sheets →
Tracking balance sheet results across Albireo Pharma inc to Dec 31 2017 helps illustrate how Dec 31 2021's financial position has responded to changing business conditions.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2021)
(Dec 31 2020) (Dec 31 2019) (Dec 31 2018) (Dec 31 2017)
Assets
Cash & cash equivalent248.11
Cash & Short-term Investments248.00
Accounts receivable3.27
Other Receivables, Net, Current0.00
Inventories0.19
Other Current Assets12.10
Prepaid Expense, Current AS5.26
Total Current Assets268.93
Equipment/Property/Plant Net0.67
Goodwill net17.26
Other Assets, Noncurrent15.19
Total Assets302.05
Liabilities
Accounts Payable, Trade, Current6.52
Accrued Liabilities, Current AC35.95
Other Liabilities, Current2.88
Total Current Liabilities45.35
Long-term debt10.00
Total Long-term Debt10.00
Other liabilities, Noncurrent71.09
Total Liabilities126.44
Stockholders' Equity
Common Stock Value0.19
Additional Paid In Capital Common Stock475.39
Retained Earnings / Accumulated Deficit-300.85
Other Equity0.88
Common Stockholder's Equity175.61
Total Stockholder's Equity175.61
Liabilities & Stockholder's Equity302.05
4 historic quarters locked

Sign in to unlock the full Albireo Pharma inc balance sheet history.

About Albireo Pharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-22-016893

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License